NVP Associates
Latest statistics and disclosures from NVP Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MBX, BLLN, ZBIO, OMDA, GROV, and represent 100.00% of NVP Associates's stock portfolio.
- Reduced shares in these 1 stock: TALK (-$36M).
- Sold out of its position in TALK.
- NVP Associates was a net seller of stock by $-36M.
- NVP Associates has $176M in assets under management (AUM), dropping by -30.97%.
- Central Index Key (CIK): 0001545692
Tip: Access up to 7 years of quarterly data
Positions held by NVP Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for NVP Associates
NVP Associates holds 5 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mbx Biosciences (MBX) | 36.2 | $64M | 2.1M | 29.85 |
|
|
| Billiontoone Cl A (BLLN) | 23.0 | $41M | 513k | 78.94 |
|
|
| Zenas Biopharma (ZBIO) | 20.4 | $36M | 1.8M | 19.55 |
|
|
| Omada Health (OMDA) | 18.1 | $32M | 2.5M | 12.57 |
|
|
| Grove Collaborative Hold Com Cl A (GROV) | 2.3 | $4.1M | 3.2M | 1.28 |
|
Past Filings by NVP Associates
SEC 13F filings are viewable for NVP Associates going back to 2022
- NVP Associates 2026 Q1 filed May 15, 2026
- NVP Associates 2025 Q4 filed Feb. 17, 2026
- NVP Associates 2025 Q3 filed Nov. 14, 2025
- NVP Associates 2025 Q2 filed Aug. 14, 2025
- NVP Associates 2025 Q1 filed May 12, 2025
- NVP Associates 2024 Q4 filed Feb. 10, 2025
- NVP Associates 2024 Q3 filed Nov. 12, 2024
- NVP Associates 2024 Q2 filed Aug. 13, 2024
- NVP Associates 2024 Q1 filed May 10, 2024
- NVP Associates 2023 Q4 filed Feb. 14, 2024
- NVP Associates 2023 Q3 filed Nov. 8, 2023
- NVP Associates 2023 Q2 filed Aug. 1, 2023
- NVP Associates 2023 Q1 filed May 15, 2023
- NVP Associates 2022 Q4 filed Feb. 14, 2023